Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phone therapy shows promise for depression in ovarian cancer patients

NCT ID NCT00515372

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 40 times

Summary

This study looks at whether weekly phone counseling can help identify and treat depression in women with ovarian, peritoneal, or fallopian tube cancer. About 409 participants will either receive phone counseling or standard care with resource lists. The goal is to see which approach better improves quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Telephone counseling

What this could lead to

If successful, this could provide a simple, effective way to identify and treat depression in ovarian cancer patients, improving their quality of life.

What could go wrong

This is an early-phase behavioral study, so results may not be definitive. The intervention is phone-based, which may not work for everyone, and the study is not testing a drug or cure.

Conditions

The condition(s) this trial relates to.

Depression fallopian tube neoplasm ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.